Long-term outcomes of IL-2R antibody vs antithymocyte globulin for induction therapy in kidney transplantation

Affiliations

Comment

George W Burke 3rd et al. Nat Clin Pract Nephrol. 2007 Mar.

. 2007 Mar;3(3):134-5.

doi: 10.1038/ncpneph0393. Epub 2007 Jan 23.

¹ University of Miami Miller School of Medicine, Department of Surgery, Division of Transplantation, Miami, FL 33101, USA. gburke@med.miami.edu

No abstract available

Comment on

Long-term results (10 years) of a prospective trial comparing Lo-tact-1 monoclonal antibody and anti-thymocyte globulin induction therapy in kidney transplantation.
Beaudreuil S, Durrbach A, Noury J, Ducot B, Kriaa F, Bazin H, Charpentier B. Beaudreuil S, et al. Transpl Int. 2006 Oct;19(10):814-20. doi: 10.1111/j.1432-2277.2006.00357.x. Transpl Int. 2006. PMID: 16961773 Clinical Trial.